Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)

NCT00050622 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

154

Enrollment

OTHER

Sponsor class

Conditions

Attention Deficit Disorder With Hyperactivity

Interventions

DRUG: Methylphenidate 0.15 mg/kg
BEHAVIORAL: Low-Intensity BMOD
DRUG: Methylphenidate 0.3 mg/kg
DRUG: Placebo
DRUG: Methylphenidate 0.6 mg/kg
BEHAVIORAL: High Intensity BMOD

Sponsor

Florida International University

Collaborators

[object Object]